Laundry startup unfolds new service in Houston

now in Hou

Hampr Lite will give Houstonians a taste of what it's laundry service is like. Image courtesy of Hampr

As Laurel Hess sat on a video call with a board member for her startup laundry service, a pile of laundry was peeking behind her.

“How can you have clothes piling up while owning a laundry business?” they asked.

Hess coolly replied, “Because laundry just doesn’t stop. It’s literally always there.”

Hampr is a hyper-local laundry and pick-up service that is connected and operated through an online app. The Lafayette-based company, which identified Houston as an early test market, links people who are in need of pick-up and wash laundry services with people in the local communities who are seeking work without leaving home.

A majority of the “washrs” who Hampr employs are stay-at-home parents and retirees who are looking for fast and steady work.

“People tend to think that we are this big national brand, but we are actually working with people in your market and you’re helping them by outsourcing your laundry,” says Hess, Hampr's foudner and CEO. “By using our service, you’re making a difference in the lives of the people who live in your community. It’s neighbors helping neighbors.”

The biggest challenge for the startup was finding the right network and getting investor interest. Hampr was part of the TechStars Austin Accelerator program and that helped expand their network and spring boarded the company on to a more national platform.

“Probably breaking out of the ecosystem was our biggest challenge that we faced,” Hess says. “Because there’s not a lot of peer-to-peer marketplace companies in Lafayette, Louisiana.”

Laurel Hess is the founder and CEO of Hampr. Photo courtesy of Hampr

Hess started the company in January 2020 and began pushing into new markets at the height of the pandemic. Hampr launched into its second market, Baton Rouge, the day that the shutdown happened.

“At first, we were a little nervous. The capital that we were raising had kind of gone away,” Hess says. “Investors were getting a little bit weary of what was going to happen.”

Two things then were true – Hampr didn’t have a lot of capital, but it also had demand in Houston – specifically The Woodlands/Kingwood area, as well as demand in DFW and New Orleans. Hess and her team then made the decision to launch in those markets, relying only on the people they knew in those areas and without any capital expenses.

“We had to do a lot with little – we didn’t have a whole lot of runway left,” she says.

Hess and her team began securing investors through their current networks in places like Houston. Then, a few months into the pandemic, they partnered with a health system to borrow the Hampr technology for PrestoHealth, a platform that delivers prescriptions. By harnessing the technology for another use, it became a way to earn more income for Hampr and they were able to launch into more new markets very quickly.

“The model itself is pretty solid and is deceptively simple,” Hess says. “Our COO in Houston grew the area without any capital investment. That’s how we were able to grow and survive the pandemic. And then once kids started back at school in August, things got crazy again and the laundry side started to pick up.”

The platform, which starts at $39 a year, is available Houston, Tomball, Conroe, The Woodlands, Kingwood as well as San Antonio, Austin, Dallas/Fort Worth, New Orleans, Baton Rouge, Lafayette, Jackson, Miss., Mobile, Alab., Jacksonville, Fla., Greenville/Spartanburg, South Carolina, Phoenix, Ariz., and Denver, Colo.

This week, the company rolled out a new service called Hampr Lite, where customers can pay a little more per load but can use it as an entry point into the platform without a full-year commitment. The service is available in some of its markets, including Houston.

“It’s kind of amazing because once you realize how much mental gymnastics that laundry takes from your weekend. You start to see what you can accomplish when you’re not worried about moving clothes from the washer to the dryer,” she says. “Then you realize there’s so much more room in your life for activities.”

Hampr gives stay-at-home parents or retirees an income option. Photo courtesy of Hampr

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings